Skip to main content

Parabilis Medicines, Inc.

PBLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001657677

In the last 90 days, Parabilis Medicines, Inc. insiders filed 2 open-market purchases and 0 sales; 79 institutions reported holding it in 13F filings for Q2 2026, worth $2.71B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Parabilis Medicines, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
2 filings
2 insiders, $16.9M in total
Open-market sells
0 filings
Insiders trading
2
Net value
+$16.9M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Parabilis Medicines, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Parabilis Medicines, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Tendler CraigDirector–Aug 25, 20261
RA Capital Healthcare Fund LPDirector, 10% Owner26,529,686IndirectJul 22, 20263
Ra Capital Management, L.P.Director, 10% Owner26,529,686IndirectJul 22, 20263
Kolchinsky PeterDirector, 10% Owner26,529,686IndirectJul 22, 20263
Shah Rajeev M.Director, 10% Owner26,529,686IndirectJul 22, 20263
RA Capital Nexus Fund III, L.P.Director26,529,686IndirectJul 22, 20263
Soleus Capital, LLC10% Owner527,070IndirectJun 29, 20261
Soleus Capital Management, L.P.10% Owner527,070IndirectJun 29, 20261
Soleus Capital Master Fund, L.P.10% Owner527,070IndirectJun 29, 20261
Soleus Capital Group, LLC10% Owner527,070IndirectJun 29, 20261
Levy Guy10% Owner527,070IndirectJun 29, 20261
Soleus Private Equity GP III, LLC10% Owner527,070IndirectJun 29, 20261
Soleus Private Equity Fund III, L.P.10% Owner527,070IndirectJun 29, 20261
Soleus GP, LLC10% Owner527,070IndirectJun 29, 20261
Soleus PE GP III, LLC10% Owner527,070IndirectJun 29, 20261
Sebulsky AlanDirector30,000IndirectJun 16, 20263
Fitzgerald Edward MDirector14,688Jun 15, 20262
Borisy AlexisDirector105,414Jun 15, 20262
Deerfield Management Company, L.P.10% Owner, Other: Possible Member of 10% Group940,352IndirectJun 11, 20261
Flynn James E10% Owner, Other: Possible Member of 10% Group940,352IndirectJun 11, 20261
Deerfield Private Design Fund III, L.P.10% Owner, Other: Possible Member of 10% Group940,352IndirectJun 11, 20261
Deerfield Mgmt III, L.P.10% Owner, Other: Possible Member of 10% Group940,352IndirectJun 11, 20261
Deerfield Healthcare Innovations Fund, L.P.10% Owner, Other: Possible Member of 10% Group940,352IndirectJun 11, 20261
Deerfield Mgmt HIF, L.P.10% Owner, Other: Possible Member of 10% Group940,352IndirectJun 11, 20261
Yeshwant KrishnaDirector–Jun 11, 20261
Klausner RichardDirector–Jun 11, 20261
Weber BarbaraDirector–Jun 11, 20261
Simson JakeDirector–Jun 11, 20261

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 22, 2026 (view filing)4:55 PM ETJul 20-222 daysRA Capital Healthcare Fund LP and 4 othersDirector, 10% OwnerPPurchaseVoting Common Stock+244.6K$28.29+$6.92M+0.9%26.5M after6 lots
Jun 29, 2026 (view filing)10:41 AM ETJun 1118 daysLateSoleus Capital, LLC and 8 others10% OwnerPPurchaseCommon Stock, par value $0.0001 per share+500.0K$20.00+$10.0M+328.9%652.0K after2 lots
Jun 16, 2026 (view filing)Jun 12-154 daysSebulsky AlanDirectorPPurchase+17.5K$27.06+$473.6K+140.0%30.0K after3 lots
Jun 15, 2026 (view filing)6:57 PM ETJun 114 daysRA Capital Healthcare Fund LP and 4 othersDirector, 10% OwnerPPurchaseVoting Common Stock+21.2M$20.00+$423.8MNew position2.65M after2 lots
Jun 15, 2026 (view filing)Jun 114 daysSebulsky AlanDirectorPPurchase+12.5K$20.00+$250.0KNew position12.5K after